WuXi AppTec stock: October 27 results date is set for WuXi AppTec stock

Published on 10/19/2026 at 17:17 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

First-half revenue was RMB 28.90 billion, up 38.93 percent. WuXi AppTec stock costs EUR 22.11 on October 19, 2026, 0.36 percent above Xetra close.

Results date and valuation

WuXi AppTec is scheduled to report third-quarter results on October 27, 2026.
First-half 2026 revenue reached RMB 28.90 billion, up 38.93 percent year over year.
WuXi AppTec stock costs EUR 22.11 at Lang & Schwarz on October 19, 2026 at 5:06 p.m. CEST, 0.36 percent above the Xetra close of October 16, 2026.
The stock carries a P/E ratio of 19.69 and a market capitalization of USD 71.3 billion as of October 19, 2026.

WuXi AppTec, CNE100003F19, Illustration mit AI erstellt.

WuXi AppTec is scheduled to report third-quarter 2026 results on October 27, 2026, according to Simply Wall St. The date gives investors the next fixed checkpoint after a volatile October trading stretch. First-half 2026 revenue reached RMB 28.90 billion, up 38.93 percent year over year, according to WuXi AppTec. The stock was trading at EUR 22.11 at Lang & Schwarz on October 19, 2026 at 5:06 p.m. CEST, 0.36 percent above the Xetra close of October 16, 2026.

Interim growth sets the baseline

The first-half revenue figure remains the clearest operating reference ahead of the October 27 release. WuXi AppTec said the period benefited from demand across its contract research, development and manufacturing organization services, which support drug development from discovery through commercial production.

The comparison is material because the company entered the second half with a higher revenue base than in the year-earlier period. The 38.93 percent increase also provides a concrete benchmark for the third-quarter update, when investors will assess whether growth remained broad across chemistry, biology and testing services.

Price position after the close

The Lang & Schwarz quote was EUR 22.11, while the Xetra close used for the daily comparison was EUR 22.03. The resulting change was plus 0.36 percent. The bid was EUR 21.94 and the ask EUR 22.28 at the same quote timestamp.

WuXi AppTec's underlying Shanghai listing closed at CNY 144.30 on October 16, 2026, down 6.60 percent from CNY 154.50, according to Global Banking and Finance. That separate home-market move is not combined with the euro quotation.

Valuation and peer comparison

The finance figures put WuXi AppTec at a P/E ratio of 19.69 and a market capitalization of USD 71.3 billion as of October 19, 2026. A dividend yield of 0.01 was also reported for the same date.

Comparison with peers

WuXi AppTec: plus 0.36 percent, P/E 19.69, market capitalization USD 71.3 billion.

WuXi Biologics (HKEX, HKD): minus 0.90 percent, P/E 34.52, market capitalization HKD 198.4 billion.

Pharmaron Beijing (SZSE, CNY): plus 5.80 percent, P/E 39.69, market capitalization CNY 56.9 billion.

Trading view before results

The October 27 reporting date and the first-half revenue comparison give the next results release a defined measuring point. For the stock, the immediate market frame is the narrow 0.36 percent premium to the October 16 Xetra close alongside the wider gap between its valuation and those of the two listed peers.

The further course of trading is shown by the continuously updated real-time quote of WuXi AppTec stock.